Harmonising Individual Patient Level Cardiac Registry Data Across the Asia Pacific Region—A Feasibility Study of In-Hospital Outcomes of STEMI Patients From the Asia Pacific Evaluation of Cardiovascular Therapies (ASPECT) Network - 28/02/23
, HuiJun Chih, PhD a, Stephen J. Duffy, MBBS, PhD b, c, Angela L. Brennan, CCRN b, Andrew E. Ajani, MBBS, MD b, d, John Beltrame, MBBS, PhD e, Rosanna Tavella, PhD e, Bryan P. Yan, MBBS, MD f, Diem Dinh, PhD b, Chee Tang Chin, MBChB g, h, Loi Doan Do, MD, PhD i, Quang Ngoc Nguyen, MD, PhD i, Hoai T.T. Nguyen, MD, PhD i, Ika Prasetya Wijaya, MD, PhD j, Muhammad Yamin, MD, PhD j, Lusiani Rusdi, MD j, Idrus Alwi, MD, PhD j, Kui Hian Sim, MBBS k, l, Alan Yean Yip Fong, MBChB k, l, Wan Azman Wan Ahmad, MRCP l, m, Khung Keong Yeo, MBBS g, hon behalf of the
ASPECT Investigators
Abstract |
Objective |
The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration was established to inform on percutaneous coronary intervention (PCI) in the Asia-Pacific Region. Our aims were to (i) determine the operational requirements to assemble an international individual patient dataset and validate the processes of governance, data quality and data security, and subsequently (ii) describe the characteristics and outcomes for ST-elevation myocardial infarction (STEMI) patients undergoing PCI in the ASPECT registry.
Methods |
Seven (7) ASPECT members were approached to provide a harmonised anonymised dataset from their local registry. Patient characteristics were summarised and associations between the characteristics and in-hospital outcomes for STEMI patients were analysed.
Results |
Six (6) participating sites (86%) provided governance approvals for the collation of individual anonymised patient data from 2015 to 2017. Five (5) sites (83%) provided >90% of agreed data elements and 68% of the collated elements had <10% missingness. From the registry (n=12,620), 84% were male. The mean age was 59.2±12.3 years. The Malaysian cohort had a high prevalence of previous myocardial infarction (34%), almost twice that of any other sites (p<0.001). Adverse in-hospital outcomes were the lowest in Hong Kong whilst in-hospital mortality varied from 2.7% in Vietnam to 7.9% in Singapore.
Conclusions |
Governance approvals for the collation of individual patient anonymised data was achieved with a high level of data alignment. Secure data transfer process and repository were established. Patient characteristics and presentation varied significantly across the Asia-Pacific region with this likely to be a major predictor of variations in the clinical outcomes observed across the region.
Le texte complet de cet article est disponible en PDF.Keywords : Cardiovascular outcome, STEMI, Registry, Asia-Pacific
Plan
Vol 32 - N° 2
P. 166-174 - février 2023 Retour au numéro
Article précédent
- Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing
- Sahan Chandrasekara, Edmund M. Lau, James Anderson, Nicholas Collins, Rachael Cordina, Carolyn Corrigan, Nathan Dwyer, John Feenstra, Mark Horrigan, Anne Keogh, Eugene Kotlyar, Melanie Lavender, Tanya McWilliams, Bronwen Rhodes, Peter Steele, Geoff Strange, Vivek Thakkar, Robert Weintraub, Helen Whitford, Kenneth Whyte, Trevor Williams, Jeremy Wrobel, Dominic T. Keating, PHSANZ Registry
- Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes: Long-Term Outcomes From the CONFIRM Registry
- Juhwan Lee, Kashif Shaikh, Rine Nakanishi, Heidi Gransar, Stephan Achenbach, Mouaz H. Al-Mallah, Daniele Andreini, Jeroen J. Bax, Daniel S. Berman, Filippo Cademartiri, Tracy Q. Callister, Hyuk-Jae Chang, Kavitha Chinnaiyan, Benjamin J.W. Chow, Ricardo C. Cury, Augustin DeLago, Gudrun Feuchtner, Martin Hadamitzky, Joerg Hausleiter, Philipp A. Kaufmann, Yong-Jin Kim, Jonathon A. Leipsic, Erica Maffei, Hugo Marques, Pedro de Araújo Gonçalves, Gianluca Pontone, Ronen Rubinshtein, Todd C. Villines, Yao Lu, Jessica M. Peña, Fay Y. Lin, James K. Min, Leslee J. Shaw, Matthew J. Budoff
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?